Pivotal phase 3 study of Zanubrutinib vs Ibrutinib in R/R CLL/SLL

 IMAGE   06/2020

Pivotal phase 3 study of Zanubrutinib vs Ibrutinib in R/R CLL/SLL

Rating

Rate this resource